the phase in the two European-American samples. Frequencies of the addiction-associated 3’ NrCAM haplotype were thus higher in African American abusers than in controls but lower in two samples of European-American substance abusers than in the corresponding control samples. We interpreted these phase differences as indicating that the 3’ NrCAM haplotype block was close to, but not identical with, the pathogenic haplotype.
